# MD Change Impact Declaration — CI-MD-B02-A001-001

- ID: `CI-MD-B02-A001-001`
- Stage / Attempt / Baseline / Epoch: `MD-B02` / `MD-B02-A001` / `MD-B02-A001-BL001` / `MD-REBASELINE-20260820-001`
- Record class: `MUTABLE_TRACEABLE`
- Issued: 2026-08-22, after `MD-B02-A001-BL001` and before any A001 matrix, implementation, test, or current-state mutation.

## Material scope

`MD-B02` opens with one mandatory row, 38 transitional `MANDATORY_OR_CONDITIONAL` rows, four `OPTIONAL_CAPABILITY` rows, and one reference-only member reported in a mixed-classification run. This attempt must perform the `MD-DEP-0004` entry obligation before treating the denominator as final: bind semantic parent/context, resolve applicability, correct mood-based classification, validate proof ownership, and move any predicate whose behavior belongs to another stage. Only the resulting MD-B02-owned predicates may be advanced by current proof.

The authority scope is `MD-S001-R0063` and the current `MD-S059` Yahoo-bootstrap/provider-boundary rule family. Initial row identity is discovery input, not a promised denominator; normalization may promote a semantic predicate or move a proof obligation without changing strategy bytes.

## Planned proof and implementation method

1. Derive complete predicates from `Yahoo_Finance_Bootstrap_Source_Strategy.md`, its acquisition/resilience owner pointers, and `MARKET_DATA_PLATFORM_EOD_BASELINE.md`.
2. Inspect actual acquisition ports, provider adapter, source-mode/config selection, manual-file path, source mapping, publication boundary, and current tests.
3. Use behavioral tests where the rule governs date addressing, mapping, source selection, fallback/rejection, or canonical output. Static source/authority proof is limited to genuinely structural predicates such as layer isolation, declared capability mapping, and absence of provider vocabulary outside adapters.
4. Add positive and fail-closed proof for any unguarded current MD-B02 predicate. Fix actual code/tooling first if inspection exposes an executable defect.
5. Bind traceability only after the stage-scoped normalization/proof gate and its mutation tests pass; then evaluate compatibility, residue, evidence, relationships, and stage closure.

## Affected areas

| Area | Expected impact |
|---|---|
| Strategy | No byte or semantic change. Frozen authority is the target. |
| Schema/data/migrations | No mutation expected; provider acquisition must not redefine canonical schema. |
| Configuration/source selection | Inspect and revalidate current source-mode/default/fallback behavior; mutate only if non-conformant. |
| Runtime/API/contracts | Inspect provider-neutral port and Yahoo/manual adapters; behavioral remediation only if authority gaps are executable here. |
| Backfill/replay/operations | No execution expected unless a normalized MD-B02 predicate genuinely owns it; operational obligations may move to their proof-owning stages. |
| Tests/gates | Material: stage-scoped normalization/proof gate and focused behavioral/static guards may be added or corrected. |
| Compatibility/residue | Check Yahoo-specific leakage, silent fallback, legacy close-as-adj-close behavior, provider-as-authority assumptions, and optional paid-provider backlog residue. |
| Traceability/evidence | Material: applicability, parent/context, classification, proof ownership, evidence binding, coverage, and current state will change. |
| Dependencies/relationships | Performs the MD-B02 entry portion of `MD-DEP-0004`; stage entry depends on `SC-MD-B01-A016-001`. |
| Downstream stages | Any moved obligation remains open at its actual proof-owning stage; no downstream proof is inherited. |

## Raw artifact/storage boundary

No `storage/**` artifact is currently referenced or expected. The opening obligation is authority, source, configuration, and in-repository test proof. If a runtime probe, replay, backfill, or provider payload becomes necessary, this declaration must be updated before execution and the resulting raw artifact must be linked under `RUNTIME_ARTIFACT_AND_GOVERNED_EVIDENCE_STANDARD.md`. No recursive storage scan is authorised by this attempt.

## Risk and failure boundary

Primary risks are vacuous string proof, treating a list item without its parent as the predicate, accepting provider mapping as proof of absolute provider capability, proving only the Yahoo happy path, leaving a silent provider-specific fallback in canonical layers, or advancing rows owned by publication/coverage/ops stages. Negative proof must demonstrate that representative provider leakage, close-as-adjusted fallback, request-date drift, and partial evidence binding are rejected where applicable.

## Strategy semantic change

`NO`.

## Current status

`EXECUTED — READY FOR CLOSURE EVALUATION`.

## Actual impact and result

- Actual application-code/schema/config mutation: **none**. Current ports, adapters, mapping, source selection, and fail-closed behavior were conformant under executed revalidation; changing them merely to produce code churn was not authorised.
- Tooling/test mutation: added the explicit `MarketDataProviderBootstrapNormalization` mutation tool, the exact stage-scoped traceability/proof gate, and four mutation tests; added `MD-B02` to the classification gate's normalized-stage set.
- Traceability: the provisional `39`-row denominator was replaced by **86 mandatory**, **6 optional capability**, and **6 conditional-not-applicable** rows. All 86 mandatory predicates are bound to `E-MD-B02-A001-001`. Seventy-five reference rows were promoted to executable semantics and 20 predicates moved to their actual proof-owning stage with MD-B02 retained as supporting stage.
- Tests executed: **107 tests / 685 assertions**, all PASS. They cover provider-neutral ports, date/range addressing, capability disclosure, manual one-date rescue, provider/public-access declaration, licensing non-claim, no paid-provider backlog, adj-close null/no-fallback behavior, five fail-closed source failures, adapter behavior, residue, and gate mutations.
- Strategy changed: **NO**; `git diff --quiet -- docs/market_data/authority/strategy` returned zero.
- Storage/raw artifacts: not inspected or mutated. No current proof references a runtime/database/replay/backfill/provider-payload artifact.
- Residue: `CONFORMANT_NO_HARMFUL_RESIDUE_FOUND` for the MD-B02 scope.
- Dependency: the MD-B02 entry portion of `MD-DEP-0004` is complete; the dependency remains `OPEN_NON_BLOCKING` for unopened stages.
- Governed evidence: `E-MD-B02-A001-001`.
